ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102051 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102051; 2) Community: the network communities that were significantly associated with the response to NSC 102051; 3) Molecule: the relationships between components within communities and NSC 102051; 4) MDR: the compounds that were significantly associated with the NSC 102051.

NSC Compound Enrichment Correlation
NSC 129518 Cyclopyrethrosin 0.0267520285931239 -0.21339191
NSC 343499 CI-921: amsacrine derivative 0.0267520285931239 0.28983456
NSC 641225 Null 0.0267520285931239 0.14209692
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0267520285931239 0.25705717
NSC 661229 Null 0.0267520285931239 0.022885589
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0267520285931239 -0.11477285
NSC 668432 Null 0.0267520285931239 -0.068109483
NSC 668833 Null 0.0267520285931239 0.15879707
NSC 673455 Null 0.0267520285931239 0.0061858749
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0267520285931239 -0.28555302
Total:49  Current:25    [First] [Prev] [Next] [Last]